Diagnostik und konservative Therapie der peripheren arteriellen Verschlusskrankheit (PAVK)

Zusammenfassung

Die periphere arterielle Verschlusskrankheit (PAVK) hat eine hohe Prävalenz. Patienten mit PAVK haben ein hohes Risiko für kardiovaskuläre Ereignisse. Ein Screening von Risikopersonen durch Ermittlung des Knöchel-Arm-Index erscheint daher wichtig. Die zentrale Methode in der angiologischen Diagnostik ist die Duplexsonografie. Zur Beurteilung des Kompensationsgrads und zur Therapieplanung eignen sich ergänzend funktionelle Untersuchungsmethoden wie beispielsweise die Laufbandergometrie. In der konservativen Therapie ist die konsequente Einstellung der kardiovaskulären Risikofaktoren wichtig. Patienten mit Claudicatio intermittens sollten zu konsequentem, strukturiertem Gehtraining angehalten werden, da dies sowohl die Gehstrecke als auch die kardiovaskuläre Prognose verbessert.

Abstract

Prevalence of peripheral arterial disease (PAD) is high and patients with PAD have a high risk for cardiovascular events. Therefore it is important to screen persons at risk by measurement of ankle-brachial index. The central diagnostic method is duplex sonography. It is often useful to combine duplex sonography with functional testing such as treadmill ergometer testing. Treatment of cardiovascular risk factors is important to improve prognosis. Patients with intermittent claudication should perform an exercise training program to improve both walking distance and cardiovascular prognosis.

Schlüsselwörter

periphere arterielle Verschlusskrankheit - Duplexsonografie - kardiovaskuläre Risikofaktoren - Gehtraining

Key words

peripheral arterial disease - duplex sonography - cardiovascular risk factors - exercise training

• Literatur

• 1 Diehm C, Allenberg JR, Pittrow D et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053-2061
• 2 Lawall H, Diehm C, Pittrow P. Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). VASA 2009; 38 (Suppl. 75) S1-S72
• 3 Layden J, Michaels J, Bermingham S et al. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ 2012; 345: 4947-4950
• 4 Khan NA, Rahim SA, Anand SS et al. Does the clinical examination predict lower extremity peripheral arterial disease?. JAMA 2006; 295: 536-546
• 5 Espinola-Klein C, Rupprecht HJ, Bickel C et al. Different calculations of ankle brachial index and their impact on cardiovascular risk prediction. Circulation 2008; 118: 961-967
• 6 Resnick HE, Linsay RS, McDermott MM et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733-739
• 7 Norgren L, Hiatt W, Dormandy J et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 01) S1-S75
• 8 Espinola-Klein C. Peripheral arterial disease. Internist 2011; 52: 549-561
• 9 Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2851-2906
• 10 Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654
• 11 Espinola-Klein C, Weisser G, Jagodzinski A et al. β-blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial. Hypertension 2011; 58: 148-154
• 12 Antithrombotic Trialistsʼ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002; 324: 71-86
• 13 CAPRIE Steering Committee. A randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996; 348: 1329-1339
• 14 Fowkes FG, Price JF, Stewart MC et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010; 303: 841-848
• 15 Murphy TP, Cutlip DE, Regensteiner JG et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 2012; 125: 130-139
• 16 Kruidener LM, Nicolai SP, Rouwet EV et al. Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial. J Vasc Interv Radiol 2011; 22: 961-968
• 17 Mazari FA, Khan JA, Carradice D et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg 2012; 99: 39-48
• 18 Grag PK, Tian L, Criqui MH et al. Physical activity during daily life and mortality in peripheral arterial disease. Circulation 2006; 114: 242-248
• 19 Aung PP, Maxwell HG, Jepson RG et al. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007; (4) CD000123
• 20 Ahimastos AA, Walker PJ, Askew C et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA 2013; 309: 453-460